(Q39204996)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

PubMed publication ID

10 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Cytotoxicity and anti-inflammatory activity of methylsulfanyl-triazoloquinazolines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

13 May 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

13 May 2020

Amira M Gamal-Eldeen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

13 May 2020

Mohamed A Al-Omar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

13 May 2020

Moustafa M G Fouda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

13 May 2020

author name string

Amer M Alanazi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

13 May 2020

Mohamed A Marzouk

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

24 January 2013

1 reference

PubMed publication ID

10 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

13 May 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

13 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

13 May 2020

page(s)

1434-1446

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 May 2020

copyright license

start time

24 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Antitumor agents. Part 204: synthesis and biological evaluation of substituted 2-aryl quinazolinones

1 reference

12 December 2020

Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists

1 reference

12 December 2020

Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis in rat carrageenin-sponge implant model

1 reference

12 December 2020

Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor

1 reference

12 December 2020

Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

1 reference

12 December 2020

A blast from the past: clearance of apoptotic cells regulates immune responses.

1 reference

12 December 2020

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

12 December 2020

Synthesis of new 4(3H)-quinazolinone derivatives using 5(4H)-oxazolones

1 reference

12 December 2020

Studies on 4(1H)-quinazolinones. 5. Synthesis and antiinflammatory activity of 4(1H)-quinazolinone derivatives

1 reference

12 December 2020

Lipid mediator class switching during acute inflammation: signals in resolution.

1 reference

12 December 2020

Antimicrobial activity of some substituted triazoloquinazolines

1 reference

12 December 2020

Measurement of protein using bicinchoninic acid

1 reference

12 December 2020

Selective adenosine A2A receptor antagonists

1 reference

12 December 2020

Novel nonpeptide CCK-B antagonists: design and development of quinazolinone derivatives as potent, selective, and orally active CCK-B antagonists.

1 reference

12 December 2020

Inflammation and cancer

1 reference

12 December 2020

Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones

1 reference

12 December 2020

Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages

1 reference

12 December 2020

Enzyme-catalyzed activation of anticancer prodrugs

1 reference

12 December 2020

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

1 reference

12 December 2020

Mechanism-based in vitro screening of potential cancer chemopreventive agents

1 reference

12 December 2020

Epoxide hydrolase--polymorphism and role in toxicology

1 reference

12 December 2020

Corpse clearance defines the meaning of cell death

1 reference

12 December 2020

The molecular biology of cancer

1 reference

12 December 2020

Synthesis and pharmacological investigation of novel 1-substituted-4-phenyl-1,2,4-triazolo[4,3-a]quinazolin-5(4H)-ones as a new class of H1-antihistaminic agents

1 reference

12 December 2020

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

1 reference

12 December 2020

Advances in the discovery of novel antibacterial agents during the year 2002.

1 reference

12 December 2020

Ring-substituted quinolines as potential anti-tuberculosis agents

1 reference

12 December 2020

A new series of 2-alkoxy(aralkoxy)-[1,2,4]triazolo[1,5-a]quinazolin-5-ones as adenosine receptor antagonists.

1 reference

12 December 2020

Synthesis and pharmacological investigation of novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H1-antihistaminic agents

1 reference

12 December 2020

Points of control in inflammation

1 reference

12 December 2020

Inflammation as a tumor promoter in cancer induction

1 reference

12 December 2020

Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-ones.

1 reference

12 December 2020

Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells

1 reference

12 December 2020

Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation

1 reference

12 December 2020

Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy.

1 reference

12 December 2020

Recent advances in chemoprevention of cancer

1 reference

12 December 2020

Molecular targets of dietary agents for prevention and therapy of cancer

1 reference

12 December 2020

New pyridone, thioxopyridine, pyrazolopyridine and pyridine derivatives that modulate inflammatory mediators in stimulated RAW 264.7 murine macrophage.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.3390/MOLECULES18021434

Identifiers

DOI

10.3390/MOLECULES18021434

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json

13 May 2020

PubMed publication ID

23348996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6270609&resulttype=core&format=json